Table of contents

  • Preliminary pages
    • Title & verso pages
    • Contents
    • Acknowledgments
    • Abbreviations
    • Symbols
    • Summary
      • How many women were diagnosed with, or died from, cervical cancer?
      • How many women participated in the National Cervical Screening Program?
      • How many women rescreened early or after a reminder letter?
      • How many high-grade abnormalities were detected?
      • Data at a glance
  • Body content
    • Section 1- Introduction
      • This report
      • Overview
        • What is cervical cancer?
        • How common is cervical cancer in Australia?
        • What causes cervical cancer?
        • How do we screen for cervical cancer?
        • Why screen for cervical cancer?
        • How is cervical screening managed in Australia?
        • How do we monitor the National Cervical Screening Program?
      • What does the HPV vaccine mean for cervical screening?
      • Data
        • Data sources
        • Aboriginal and Torres Strait Islander women
        • Reporting women with symptoms
      • Terminology and concepts
        • Reporting periods
        • Age groups
        • Crude versus age-standardised
        • Confidence intervals
    • Section 2 - Performance indicators
      • Indicator 1 Participation
        • What you need to know about participation
        • What the data tell us about participation
        • Detailed analyses
    • Indicator 2.1 Early rescreening
      • What you need to know about early rescreening
      • What the data tell us about early rescreening
      • Detailed analyses
    • Indicator 2.2 Rescreening after 27-month reminder letter
      • What you need to know about rescreening after a reminder letter
      • What the data tell us about rescreening after a reminder letter
      • Detailed analyses
    • Indicator 3 Cytology
      • What you need to know about cytology
      • What the data tell us about cytology
      • More information about cytology
      • Detailed analyses
    • Indicator 4 Histology
      • What you need to know about histology
      • What the data tell us about histology
      • Detailed analyses
    • Indicator 5 Cytology-histology correlation
      • What you need to know about the cytology-histology correlation
      • What the data tell us about the cytology histology correlation
      • More information about the cytology-histology correlation
      • Detailed analyses
    • Indicator 6 Incidence
      • What you need to know about incidence
      • What the data tell us about incidence
      • More information on incidence
      • Detailed analyses
    • Indicator 7 Mortality
      • What you need to know about mortality
      • What the data tell us about mortality
      • More information about mortality
      • Detailed analyses
  • End matter
    • Appendix A Additional data
    • Appendix B National Cervical Screening Program information
    • Appendix C Data sources and classifications
      • Data sources
      • Classifications
    • Appendix D Data quality statement
      • Data Quality Statement: Cervical screening data 2011-2012
    • Appendix E Statistical methods
      • Comparisons and tests of statistical significance
    • Glossary
    • References
    • List of tables
    • List of figures
    • Related publications